Literature DB >> 10487253

Obsessive-compulsive disorder: diagnosis and treatment.

W K Goodman1.   

Abstract

Obsessive-compulsive disorder (OCD) is a chronic, disabling anxiety disorder that is characterized by recurrent obsessions and uncontrolled compulsions such as repetitive behavioral or mental acts that are performed in response to an obsession. OCD often occurs comorbidly with a number of depressive and anxiety disorders. In addition, patients with OCD suffer significant personal and social morbidity and may have difficulty maintaining a job, finishing school, and developing relationships. The backbone of pharmacologic treatment for OCD is a 10- to 12-week trial with a selective serotonin reuptake inhibitor (SSRI) in adequate doses. In most cases, treatment should be initiated with an SSRI because of the superior safety, tolerability, and equivalent efficacy of this class of drugs compared with clomipramine. When dealing with patients who do not respond to one SSRI, effective alternatives include switching to a different SSRI, combining another medication or behavioral therapy with SSRI therapy, considering novel or experimental drug treatments, or employing nonpharmacologic biological approaches, such as electroconvulsive therapy, neurosurgery, or repetitive transcranial magnetic stimulation. This article provides an update on the diagnosis and medical management of OCD and will discuss guidelines for the use of SSRIs and novel approaches for managing treatment-refractory patients.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10487253

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  9 in total

1.  Treating obsessive-compulsive and tic disorders.

Authors:  E Weir
Journal:  CMAJ       Date:  2000-07-11       Impact factor: 8.262

Review 2.  Paroxetine: an update of its use in psychiatric disorders in adults.

Authors:  Antona J Wagstaff; Susan M Cheer; Anna J Matheson; Douglas Ormrod; Karen L Goa
Journal:  Drugs       Date:  2002       Impact factor: 9.546

3.  Differential effects of acute and repeated citalopram in mouse models of anxiety and depression.

Authors:  Cedric Mombereau; Tamar L Gur; Jennifer Onksen; Julie A Blendy
Journal:  Int J Neuropsychopharmacol       Date:  2009-12-14       Impact factor: 5.176

Review 4.  Transcranial magnetic stimulation for the treatment of obsessive-compulsive disorder.

Authors:  J L R Martin; M J Barbanoj; V Pérez; M Sacristán
Journal:  Cochrane Database Syst Rev       Date:  2003

5.  Literature mining for the discovery of hidden connections between drugs, genes and diseases.

Authors:  Raoul Frijters; Marianne van Vugt; Ruben Smeets; René van Schaik; Jacob de Vlieg; Wynand Alkema
Journal:  PLoS Comput Biol       Date:  2010-09-23       Impact factor: 4.475

6.  Near-Infrared Spectroscopy during the Verbal Fluency Task before and after Treatment with Image Exposure and SSRI Therapy in Patients with Obsessive-Compulsive Disorder.

Authors:  Mari Nakanishi; Harumi Oshita; Yoshihiro Tanaka; Ayako Inoue; Chiwa Kawashima; Kana Okamoto; Shunsuke Kobayashi; Yoshinobu Ishitobi; Taiga Ninomiya; Jotaro Akiyoshi
Journal:  Case Rep Psychiatry       Date:  2014-09-16

7.  Genetic disruption of both tryptophan hydroxylase genes dramatically reduces serotonin and affects behavior in models sensitive to antidepressants.

Authors:  Katerina V Savelieva; Shulei Zhao; Vladimir M Pogorelov; Indrani Rajan; Qi Yang; Emily Cullinan; Thomas H Lanthorn
Journal:  PLoS One       Date:  2008-10-15       Impact factor: 3.240

8.  Updated overview of the putative role of the serotoninergic system in obsessive-compulsive disorder.

Authors:  Bruno Aouizerate; Dominique Guehl; Emmanuel Cuny; Alain Rougier; Pierre Burbaud; Jean Tignol; Bernard Bioulac
Journal:  Neuropsychiatr Dis Treat       Date:  2005-09       Impact factor: 2.570

9.  Tabernaemontana divaricata leaves extract exacerbate burying behavior in mice.

Authors:  Raj Chanchal; Arumugam Balasubramaniam; Raj Navin; Sayyed Nadeem
Journal:  Avicenna J Phytomed       Date:  2015 Jul-Aug
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.